Treatment of aberrant cellular states with biomodulators

Details Treatment of aberrant cellular states with biomodulators Treatment of aberrant cellular states with biomodulators

1993-09-23

1999-07-06

Woodward, Michael P.

Drug, bio-affecting and body treating compositions

Nonspecific immunoeffector, per se ; or nonspecific...

514730, 514733, 514738, 514739, 514396, 514406, 562466, 562470, 548374, 548378, A61K 4500, A61K 31045, A61K 3104

Patent

active

059194642

ABSTRACT:
Biomodulators, which regulate cellular differentiation and proliferation, as well as methods of use thereof, e.g., for treating various conditions, e.g., cancer, senescence, immunological disorders and vascular disease; for stimulating normal tissue architecture after injury; for vaccination; for stimulating the production of biologically important molecules by cells or organs in culture; for maintaining organs or tissues outside of a body after removal from the body and prior to transplantation; and for producing of vascular grafts for transplantation; are provided.

REFERENCES:
patent: 56075 (1866-07-01), Mason
patent: 85761 (1869-01-01), Penoyer
patent: 118686 (1871-09-01), Chambers
patent: 3983140 (1976-09-01), Endo et al.
patent: 4137322 (1979-01-01), Endo et al.
patent: 4198425 (1980-04-01), Mistui et al.
patent: 4248889 (1981-02-01), Oka et al.
patent: 4255444 (1981-03-01), Oka et al.
patent: 4588715 (1986-05-01), Damon, II
patent: 4613610 (1986-09-01), Wareing
patent: 4666425 (1987-05-01), Fleming
patent: 4681893 (1987-07-01), Roth
patent: 4710513 (1987-12-01), Willard et al.
patent: 4739073 (1988-04-01), Kathawala
patent: 4751235 (1988-06-01), Anderson
patent: 4755606 (1988-07-01), Wareing
patent: 4761419 (1988-08-01), Picard et al.
patent: 4808607 (1989-02-01), Wareing
patent: 5021427 (1991-06-01), Elbein et al.
Rice et al, "Chemical Determination of Leucogenenol and Its Production by Penicillium gilmanii", Applied Microbiology 15:790-793 (1967).
Rice, F.A.H., "The Structure of Leucogenenol", J. Chem. Soc. (C), pp. 2599-2605 (1971).
Hayflick, Leonard, Ann. Rev. Gerontol Gerrat 1:26-67 (1980).
Schneider et al, "Skin fibroblast cultures derived from members of the Baltimore Longitudinal Study: a new resource for studies of cellular aging", Cytogenet. Cell Genet. 31:40-46 (1981).
Martin et al, "Replicative Life-Span of Cultivated Human C", Laboratory Investigation 93(1):86-(1970).
Goldstein, Samuel, "Replicative Senescence: The Human Fibroblast Comes of Age", Science 249:1129 (1990).
Cristofalo et al, "Molecular Biology of Aging", Surgical Clinics of North America 74(1):1-21 (1994).
Mann et al, "Cell Surface Oligosaccharide Modulation During Differentiation: V. Partial Characterization of the Regulated Surface During Substrate Adhesion and Spreading", Mechanisms of Ageing and Development 62:47-77 (1992).
Kino et al, "Studies of an Immunomodularor, Swainsonine: II. Effect of Swainsonine on Mouse Immunodeficient System and Experimental Murine Tumor", The Journal of Antibiotics 38:936-940 (1985).
Humphries et al, "Augmentation of Murine Natural Killer Cell Activity by Swainsonine, a New Antimetastatic Immunomodulator", Cancer Research 48:1410-1415 (1988).
Mann et al, "Biomodulation: An integrated approach to access and manipulate biological information", In: Gabius HJ, Gabius S., eds. Lectins and Cancer, Berlin Heidelberg: Springer-Verlag; 179-206 (1991).
Bitner et al, "Enhanced Tumor Imaging with Pokeweed Mitogenp", Nucl. Med. Biol. 20(2):203-210 (1993).
Mann, "Biomodulation: an alternate approach to disease management", Curr. Opin. Invest. Drugs 2(9):1007-1014 (1993).
Mann et al, "Cell Surface Oligosaccharide Modulation During Differentiation: VI. The Effect of Biomodulation on the Senescent and Neoplastic Cell Phenotype", Mechanisms of Ageing and Development 62:79-110 (1992).
Mann, Paul, Radioimmunoimaging and Radioimmunotherapy, pp. 121-141.
Mann, Paul L. et al., Mechanisms of Ageing and Development, 44 (1988), pp. 17-33.
Mann, Paul L., Int'l Rev. of Cytology, vol. 112, pp. 67-96.
Dennis et al. (1990) "Growth Inhibition of Human . . . " Cancer Res 50:1867-1872.
Myc et al (1989) "Effect of Swainsonine . . . " Cancer Res 49:2879-2883.
Olden et al (1991) Pharmac. Ther 50:285-290.
Stoessl et al (1986) Z. Naturforsch. 41c; 677-688.
Bowlin et al (1989 Cancer Research 49:4109-4113.
Mohla et al (1990) Anticancer Res 10:1515-1522.
Rice (1966) Proc Soc Exp Biol Med 123(1):189-192 Abstract.
Reisfeld et al (1967) PNAS 58:2020-2027.
Waxdal (1974) Biochemistry 13:3671-3677.
Dennis (1966) Cancer Res 46:5131-5136.

Affiliated with

Also associated with

Rating

Treatment of aberrant cellular states with biomodulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of aberrant cellular states with biomodulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of aberrant cellular states with biomodulators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-897341